DurAVR™ THV EU-EFS
NCT: NCT06510855 · ACTIVE_NOT_RECRUITING
광고
NCT IDNCT06510855
상태ACTIVE_NOT_RECRUITING
시작일2025-01-21
SponsorAnteris Technologies Ltd. (INDUSTRY)
First posted
Last updated
간략 요약
A prospective, non-randomized, single-arm, multi-center study designed to evaluate the safety and feasibility of DurAVR™ THV System in the treatment of subjects with symptomatic severe native aortic stenosis or failed surgical aortic bioprosthetic valves.
공식 출처
ClinicalTrials.gov에서 보기 →데이터는 ClinicalTrials.gov API에서 제공됩니다. 최신 상태는 공식 기록을 확인하세요.